WEEKLY NEWSLETTER
Ankylosing Spondylitis
References
Citations
Van der Linden S, et al. (2009). Ankylosing spondylitis. In GS Firestein et al., eds., Kelley's Textbook of Rheumatology, 8th ed., vol. 2, pp. 1169–1189. Philadelphia: Saunders Elsevier.
Other Works Consulted
Braun J, Sieper J (2004). Biological therapies in spondyloarthritides—The current state. Rheumatology, 43(9): 1072–1084.
Gorman JD, et al. (2002). Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor a. New England Journal of Medicine, 346(18): 1349–1356.
Jaakkola E, et al. (2006). Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis. Annals of the Rheumatic Diseases, 65(6): 775–780.
McVeigh CM, Cairns AP (2006). Clinical review: Diagnosis and management of ankylosing spondylitis. BMJ, 333(7568): 581–585.
Zochling J, et al. (2006). ASAS/EULAR recommendations for the management of ankylosing spondylitis. Annals of the Rheumatic Diseases, 65(4): 442–452.
Last Updated:
May 14, 2009- Author:
- Shannon Erstad, MBA/MPH
- Medical Review:
- Anne C. Poinier, MD - Internal Medicine
E. Gregory Thompson, MD - Internal Medicine
Richa Dhawan, MD - Rheumatology
© 1995-2009 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.





